Breaking U.S. Scales Back Military Exercises with South Korea Amid Shifting Alliances Brazil Eyes Amazon Coast Oil Find as ‘Passport to Future’ Amid Environmental Concerns Discord Suspends Livestreaming in Brazil Amid Data Protection Concerns Vikings Place Jamal Adams on Injured Reserve, Sign Bryce Phillips Health Net to Discontinue Assisted Living Benefit, Affecting 3,500 Medi-Cal Patients in California

Tuesday August 18, 2026

Reporter

Nuvectis Pharma, Inc.

3Articles Published

5Communities Covered

Published Articles

Press Release

Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights

Aug 4

Press Release

Correction: (Title Correction) Nuvectis Announces Marketing Approval of Ciprocopan (NXP100) in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors

Jul 23

Press Release

Ciprocopan (NXP100) Receives Marketing Approval in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors

Jul 23